Patient- and Physician-Reported Pain after Tyrosine Kinase Inhibitor Discontinuation among Patients with Chronic Myeloid Leukemia

Researchers plotted the trajectory of chronic myeloid leukemia patient-reported pain over time using a piecewise mixed-effects ordinal logistic model after discontinuation of tyrosine kinase inhibitor therapy.